REPORTS

Let’s Pullulate and Expand Your Business

Global Chemotherapy-induced Nausea and Vomiting Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Feb 14, 2020  |  183 PAGES  |  REPORT CODE: CMM266821
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Chemotherapy-induced Nausea and Vomiting Drugs is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. The research provides insights for the global Chemotherapy-induced Nausea and Vomiting Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Chemotherapy-induced Nausea and Vomiting Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Chemotherapy-induced Nausea and Vomiting Drugs Market Segmentations:

By Players:

  • Heron Therapeutics

  • GlaxoSmithKline

  • Especificos Stendhal

  • Tesaro

  • Barr Laboratories

  • Eisai

  • Baxter Healthcare

  • Acacia Pharma

  • Helsinn

  • Mylan Pharmaceuticals

  • OPKO Health

  • Merck & Co

  • Orchid Healthcare

  • Mundipharma

  • Aphios

  • F.Hoffmann La Roche

By Types:

  • Aloxi (palonosetron)

  • Kytril Generic (granisetron)

  • Emend (aprepitant)

  • Akynzeo (netupitant-palonosetron)

By End-User:

  • Akynzeo (netupitant-palonosetron)

  • Akynzeo (netupitant-palonosetron)

  • Akynzeo (netupitant-palonosetron)

  • Akynzeo (netupitant-palonosetron)

  • Akynzeo (netupitant-palonosetron)

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Chemotherapy-induced Nausea and Vomiting Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Types

    • 1.3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Aloxi (palonosetron) from 2014 to 2026

    • 1.3.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Kytril Generic (granisetron) from 2014 to 2026

    • 1.3.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Emend (aprepitant) from 2014 to 2026

    • 1.3.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by End-Users

    • 1.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.6 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Chemotherapy-induced Nausea and Vomiting Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Chemotherapy-induced Nausea and Vomiting Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Aloxi (palonosetron)

    • 3.4.2 Market Size and Growth Rate of Kytril Generic (granisetron)

    • 3.4.3 Market Size and Growth Rate of Emend (aprepitant)

    • 3.4.4 Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

4 Segmentation of Chemotherapy-induced Nausea and Vomiting Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Chemotherapy-induced Nausea and Vomiting Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

    • 4.4.2 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

    • 4.4.3 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

    • 4.4.4 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

    • 4.4.5 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

5 Market Analysis by Major Regions

  • 5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Analysis by Major Regions

  • 5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Analysis by Major Regions

  • 5.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Chemotherapy-induced Nausea and Vomiting Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

  • 7.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

  • 7.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

8 Europe Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

  • 8.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

  • 8.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.2 UK Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.3 France Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

9 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

  • 9.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 9.3.4 India Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Heron Therapeutics

    • 11.1.1 Heron Therapeutics Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 GlaxoSmithKline

    • 11.2.1 GlaxoSmithKline Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Especificos Stendhal

    • 11.3.1 Especificos Stendhal Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Tesaro

    • 11.4.1 Tesaro Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Barr Laboratories

    • 11.5.1 Barr Laboratories Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Eisai

    • 11.6.1 Eisai Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Baxter Healthcare

    • 11.7.1 Baxter Healthcare Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Acacia Pharma

    • 11.8.1 Acacia Pharma Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Helsinn

    • 11.9.1 Helsinn Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Mylan Pharmaceuticals

    • 11.10.1 Mylan Pharmaceuticals Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 OPKO Health

    • 11.11.1 OPKO Health Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Merck & Co

    • 11.12.1 Merck & Co Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Orchid Healthcare

    • 11.13.1 Orchid Healthcare Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Mundipharma

    • 11.14.1 Mundipharma Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Aphios

    • 11.15.1 Aphios Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 F.Hoffmann La Roche

    • 11.16.1 F.Hoffmann La Roche Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 93 Figures and 139 Tables)

  • Figure Product Picture

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Aloxi (palonosetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Kytril Generic (granisetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Emend (aprepitant) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Chemotherapy-induced Nausea and Vomiting Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Chemotherapy-induced Nausea and Vomiting Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Chemotherapy-induced Nausea and Vomiting Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Chemotherapy-induced Nausea and Vomiting Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Aloxi (palonosetron)

  • Figure Market Size and Growth Rate of Kytril Generic (granisetron)

  • Figure Market Size and Growth Rate of Emend (aprepitant)

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Chemotherapy-induced Nausea and Vomiting Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Chemotherapy-induced Nausea and Vomiting Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

  • Table Global Chemotherapy-induced Nausea and Vomiting Drugs Production by Major Regions

  • Table Global Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Regions

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Regions in 2014

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Regions in 2018

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Regions in 2026

  • Table Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Regions

  • Table Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Regions

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Regions in 2014

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Regions in 2018

  • Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Regions in 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2014

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2018

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2014

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2018

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2014

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2018

  • Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2026

  • Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2014

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2018

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2014

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2018

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2026

  • Figure China Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandChemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Heron Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics

  • Figure Sales and Growth Rate Analysis of Heron Therapeutics

  • Figure Revenue and Market Share Analysis of Heron Therapeutics

  • Table Product and Service Introduction of Heron Therapeutics

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline

  • Table Company Profile and Development Status of Especificos Stendhal

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Especificos Stendhal

  • Figure Sales and Growth Rate Analysis of Especificos Stendhal

  • Figure Revenue and Market Share Analysis of Especificos Stendhal

  • Table Product and Service Introduction of Especificos Stendhal

  • Table Company Profile and Development Status of Tesaro

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesaro

  • Figure Sales and Growth Rate Analysis of Tesaro

  • Figure Revenue and Market Share Analysis of Tesaro

  • Table Product and Service Introduction of Tesaro

  • Table Company Profile and Development Status of Barr Laboratories

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Barr Laboratories

  • Figure Sales and Growth Rate Analysis of Barr Laboratories

  • Figure Revenue and Market Share Analysis of Barr Laboratories

  • Table Product and Service Introduction of Barr Laboratories

  • Table Company Profile and Development Status of Eisai

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

  • Figure Sales and Growth Rate Analysis of Eisai

  • Figure Revenue and Market Share Analysis of Eisai

  • Table Product and Service Introduction of Eisai

  • Table Company Profile and Development Status of Baxter Healthcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter Healthcare

  • Figure Sales and Growth Rate Analysis of Baxter Healthcare

  • Figure Revenue and Market Share Analysis of Baxter Healthcare

  • Table Product and Service Introduction of Baxter Healthcare

  • Table Company Profile and Development Status of Acacia Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acacia Pharma

  • Figure Sales and Growth Rate Analysis of Acacia Pharma

  • Figure Revenue and Market Share Analysis of Acacia Pharma

  • Table Product and Service Introduction of Acacia Pharma

  • Table Company Profile and Development Status of Helsinn

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn

  • Figure Sales and Growth Rate Analysis of Helsinn

  • Figure Revenue and Market Share Analysis of Helsinn

  • Table Product and Service Introduction of Helsinn

  • Table Company Profile and Development Status of Mylan Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals

  • Table Product and Service Introduction of Mylan Pharmaceuticals

  • Table Company Profile and Development Status of OPKO Health

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OPKO Health

  • Figure Sales and Growth Rate Analysis of OPKO Health

  • Figure Revenue and Market Share Analysis of OPKO Health

  • Table Product and Service Introduction of OPKO Health

  • Table Company Profile and Development Status of Merck & Co

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

  • Figure Sales and Growth Rate Analysis of Merck & Co

  • Figure Revenue and Market Share Analysis of Merck & Co

  • Table Product and Service Introduction of Merck & Co

  • Table Company Profile and Development Status of Orchid Healthcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orchid Healthcare

  • Figure Sales and Growth Rate Analysis of Orchid Healthcare

  • Figure Revenue and Market Share Analysis of Orchid Healthcare

  • Table Product and Service Introduction of Orchid Healthcare

  • Table Company Profile and Development Status of Mundipharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma

  • Figure Sales and Growth Rate Analysis of Mundipharma

  • Figure Revenue and Market Share Analysis of Mundipharma

  • Table Product and Service Introduction of Mundipharma

  • Table Company Profile and Development Status of Aphios

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aphios

  • Figure Sales and Growth Rate Analysis of Aphios

  • Figure Revenue and Market Share Analysis of Aphios

  • Table Product and Service Introduction of Aphios

  • Table Company Profile and Development Status of F.Hoffmann La Roche

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F.Hoffmann La Roche

  • Figure Sales and Growth Rate Analysis of F.Hoffmann La Roche

  • Figure Revenue and Market Share Analysis of F.Hoffmann La Roche

  • Table Product and Service Introduction of F.Hoffmann La Roche


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top